Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Recent trends in the treatment of chronic hepatitis C

Dae Won Jun, Won Young Tak, Si Hyun Bae, Youn Jae Lee

Clin Mol Hepatol. 2012;18(1):22-28. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.22

View: 10350 Download: 65 Crossref: 9

Revision and update on clinical practice guideline for liver cirrhosis

Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang

Clin Mol Hepatol. 2012;18(1):1-21. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.1

View: 65535 Download: 186 Crossref: 108

Original Article

A study of the awareness of chronic liver diseases among Korean adults

Dae Won Jun, Yong Kyun Cho, Joo Hyun Sohn, Chang Hyeong Lee, Seok Hyun Kim, Jong Ryul Eun

Clin Mol Hepatol. 2011;17(2):99-105. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.99

View: 8047 Download: 53 Crossref: 12

Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis

Mi Yeon Chung, Dae Won Jun, Su Ah Sung

Clin Mol Hepatol. 2010;16(3):301-307. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.301

View: 10095 Download: 77 Crossref: 19

Reply to Correspondence

Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”

Eileen Laurel Yoon, Dae Won Jun

Received May 15, 2024 Accepted May 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0360 [Epub ahead of print]

View: 531 Download: 14

Correspondence

Correspondence on Editorial regarding “Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care”

Hee Yeon Kim, Miyoung Choi, Dae Won Jun

Received September 9, 2024 Accepted September 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0777 [Accepted]

View: 165 Download: 6

Reply to Letter regarding “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”

Yuri Cho, Dae Won Jun

Received September 19, 2024 Accepted September 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0818 [Accepted]

View: 147 Download: 3

1 | 2 |

Viewed By 4934	MAFLD: How is it different from NAFLD?
Viewed By 4828	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4728	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4446	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4402	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search